Group One Trading’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-15,700
Closed -$18.2K 8388
2023
Q1
$18.2K Buy
15,700
+11,000
+234% +$20.1K ﹤0.01% 5574
2022
Q4
$12.6K Sell
4,700
-4,900
-51% -$12.9K ﹤0.01% 5905
2022
Q3
$27K Buy
9,600
+6,600
+220% +$28.1K ﹤0.01% 5893
2022
Q2
$15K Sell
3,000
-2,100
-41% -$11K ﹤0.01% 6536
2022
Q1
$36K Buy
5,100
+1,600
+46% +$13.2K ﹤0.01% 6363
2021
Q4
$64K Sell
3,500
-15,200
-81% -$328K ﹤0.01% 6136
2021
Q3
$366K Buy
18,700
+5,200
+39% +$198K ﹤0.01% 4538
2021
Q2
$605K Sell
13,500
-16,500
-55% -$765K ﹤0.01% 4008
2021
Q1
$1.51M Buy
+30,000
New +$2.05M ﹤0.01% 2769

Other funds holding CELL

Group One Trading's CELL Position: Q4 2022 in Review

Group One Trading sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2022, closing a stake of 2,413 shares — an estimated $6.36K sold.

Group One Trading first reported a position in CELL in Q3 2021 and held it in 5 quarters. The position peaked at $465K in Q4 2021. 117 funds tracked by Wall St. Rank hold CELL as of Q4 2022.

  • Group One Trading reported no remaining PhenomeX Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Group One Trading sold 2,413 PhenomeX Inc. Common Stock shares in Q4 2022, an estimated $6.36K.
  • Group One Trading first reported a position in PhenomeX Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Group One Trading's PhenomeX Inc. Common Stock position peaked at $465K in Q4 2021.
  • 117 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2022.

Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.